National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018

National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018

Recommendations for the treatment of chronic obstructive pulmonary disease (COPD) have shifted towards a more restrictive use of inhaled corticosteroids (ICS). We aimed to identify the nationwide development over time in the use of ICS treatment in COPD. We conducted a register-based repeated cross-...

Full description

Bibliographic Details
Main Authors:	Allan Klitgaard, Rikke Ibsen, Jesper Lykkegaard, Ole Hilberg, Anders Løkke
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Biomedicines
Subjects:	chronic obstructive pulmonary disease inhaled corticosteroids inhaled medication pharmacoepidemiology treatment recommendations nationwide development
Online Access:	https://www.mdpi.com/2227-9059/12/2/372

Similar Items

Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease – nationwide development from 1998 to 2018
by: Allan Klitgaard, et al.
Published: (2024-12-01)

The Impact of Inhaled Corticosteroids on the Prognosis of Chronic Obstructive Pulmonary Disease
by: Park JW, et al.
Published: (2023-05-01)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
by: Lugogo N, et al.
Published: (2023-05-01)

Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
by: Ye Jin Lee, et al.
Published: (2023-07-01)

Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
by: Rosario Lineros, et al.
Published: (2023-04-01)

Inhaled Corticosteroids and the Lung Microbiome in COPD
by: Holly R. Keir, et al.
Published: (2021-09-01)

Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
by: Amir Hossein Alizadeh Bahmani, et al.
Published: (2025-01-01)

Is underuse of Inhaled Corticosteroids for Asthma in India contributing to 42% of global asthma deaths?
by: Sundeep Salvi, et al.
Published: (2022-01-01)

Hematological Profiles of Nigerian Patients with Asthma on Inhaled Corticosteroids
by: Hayatu S, et al.
Published: (2021-10-01)

Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids
by: G.I. Butel-Simoes, et al.
Published: (2023-12-01)

Laryngeal candidiasis due to inhaled corticosteroid: a case report
by: Utku Kubilay, et al.
Published: (2005-12-01)

Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
by: Hirano R, et al.
Published: (2018-10-01)

OCCURRENCE OF ORAL CANDIDIASIS AMONG BRONCHIAL ASTHMA PATIENTS ON INHALED CORTICOSTEROIDS
by: Pooja M Patel, et al.
Published: (2021-03-01)

EARLY PRESCRIPTION OF INHALATION CORTICOSTEROID IN BRONCHIAL ASTHMA
by: Z. R. Aisanov, et al.
Published: (2017-11-01)

Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History
by: Andrea S. Melani, et al.
Published: (2024-02-01)

Efficacy of Inhaled Corticosteroids in Patients with Bronchiectasis without Airway Hyperresponsiveness: A Pilot Study
by: Safia Ahmed, et al.
Published: (2024-11-01)

A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations
by: SR Downie, et al.
Published: (2002-01-01)

In vitro Evaluation of Dry Powder Inhaler Devices of Corticosteroid Preparations
by: Gen Tamura, et al.
Published: (2012-01-01)

Oral health status of asthmatic children using inhaled corticosteroids
by: Münevver Doğan, et al.
Published: (2021-02-01)

The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
by: Ricardo G. Figueiredo, et al.
Published: (2022-08-01)

Laryngeal dysfunction is prominent in asthmatic women treated by inhaled corticosteroids
by: Nicolas Migueres, et al.
Published: (2022-12-01)

Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
by: Pontus Mertsch, MD, et al.
Published: (2022-10-01)

Severe disseminated primary varicella in a patient on long term inhaled corticosteroids
by: James P. Pham, et al.
Published: (2022-09-01)

Regional variation in intensity of inhaled asthma medication and oral corticosteroid use in Denmark, Finland, and Sweden
by: Lauri Lehtimäki, et al.
Published: (2022-12-01)

Effects of Asthma and Inhalation corticosteroids on the dental arch morphology in children
by: S S Kumar, et al.
Published: (2012-01-01)

Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study
by: Heerfordt CK, et al.
Published: (2023-03-01)

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey
by: Miravitlles M, et al.
Published: (2022-07-01)

Study protocol: pneumonia and inhaled corticosteroid treatment patterns in chronic obstructive pulmonary disease – a cohort study using sequence analysis (PICCS)
by: Anders Løkke, et al.
Published: (2023-06-01)

Breathomics in Asthmatic Children Treated with Inhaled Corticosteroids
by: Valentina Agnese Ferraro, et al.
Published: (2020-09-01)

Association between inhaled corticosteroid use and risk of hyperglycemia in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Fathur Nur Kholis, et al.
Published: (2023-01-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

Bone mineral density in asthmatic patients on inhaled corticosteroids in a developing country
by: Yeh Chunn Kuan, et al.
Published: (2012-01-01)

The Effects of Inhaled Corticosteroids on Bone Mineral Density, Bone Formation/Resorption Markers, and Quality of Life in Premenopausal Asthmatic Women
by: Arzu Atıcı, et al.
Published: (2023-03-01)

Inhaled Corticosteroids Particle Size and Risk of Hospitalization Due to Exacerbations and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. A Nationwide Cohort Study
by: Heerfordt CK, et al.
Published: (2024-09-01)

The Effect of Inhaled Corticosteroid Therapy on Periodontal Status in Patients with Asthma
by: Elżbieta Dembowska, et al.
Published: (2021-12-01)

Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting
by: Whittaker HR, et al.
Published: (2019-05-01)

A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease
by: Marc Miravitlles, et al.
Published: (2017-11-01)

Several Nocardia abcessus bronchiolitis in a patient treated with inhaled corticosteroids: a case report
by: Estelle Cascarano, et al.
Published: (2023-04-01)

Effect of outpatient therapy with inhaled corticosteroids on decreasing in-hospital mortality from pneumonia in patients with COPD
by: Yamauchi Y, et al.
Published: (2016-06-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)